Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies

被引：0
|
作者：
Michael Rainone
Tanya Siddiqi
机构：
[1] City of Hope,Department of Hematology and Medical Oncology
[2] City of Hope,Department of Hematology & Hematopoietic Cell Transplantation
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Chronic lymphocytic leukemia; Small lymphocytic lymphoma; Ibrutinib; Acalabrutinib; Venetoclax; Chimeric antigen receptor (CAR) T cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 45
页数：6
相关论文
共 50 条
  • [41] Chronic lymphocytic leukemia/small lymphocytic lymphoma involving the aortic valve
    Chiste, Marcela
    Vrotsos, Elena
    Zamora, Carlos
    Martinez, Antonio
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (03) : 295 - 297
  • [42] Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia
    Puckrin, Robert
    Owen, Carolyn
    Peters, Anthea
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 636 - 640
  • [43] Pathology of Seminoma Coinciding With Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
    Bui, Katherine M.
    Zhang, Hailing
    Boac, Bernadette M.
    Chatwal, Monica S.
    Dhillon, Jasreman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [44] Acalabrutinib: a real breakthrough in the management of relapsed or refractory chronic lymphocytic leukemia?
    Nsiala, Laly
    Tomowiak, Cecile
    HEMATOLOGIE, 2020, 26 (03): : 146 - 147
  • [45] Comparative safety of novel targeted therapies in relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis
    Monica, Magdalena
    Reczek, Monika
    Kawalec, Pawel
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [46] Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
    Huntington, Scott F.
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    De Nigris, Enrico
    LEUKEMIA & LYMPHOMA, 2024, : 932 - 942
  • [47] Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
    Xu, Wei
    Yang, Shenmiao
    Zhou, Keshu
    Pan, Ling
    Li, Zengjun
    Zhou, Jianfeng
    Gao, Sujun
    Zhou, Daobin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Ji, Meng
    Guo, Haiyi
    Huang, Jane
    Novotny, William
    Feng, Shibao
    Li, Jianyong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [48] The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Zou, Yi-Xin
    Zhu, Hua-Yuan
    Li, Xiao-Tong
    Xia, Yi
    Miao, Kou-Rong
    Zhao, Si-Shu
    Wu, Yu-Jie
    Wang, Li
    Xu, Wei
    Li, Jian-Yong
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 392 - 400
  • [49] Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Viswanathan, Kartik
    Roboz, Gail
    Chadburn, Amy
    Mathew, Susan
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (02) : 216 - 224
  • [50] Next-Generation Sequencing-Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Simon, Florian
    Bohn, Jan-Paul
    CURRENT ONCOLOGY REPORTS, 2023, 25 (10) : 1181 - 1189
12345